Log in to your account:
Bristol-Myers Squibb (BMY) Trades at Low, Down 3.4%
March 14, 2019 10:56 AM
Bristol-Myers Squibb ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Celgene (CELG) Revlimid Patent Escapes IPR Review Sought by Alvogen - Bloomberg
March 14, 2019 7:59 AM